World Health Organisation approves malaria vaccine for children

The world’s first malaria vaccine is to be considered for use in national immunisation programmes after being given the scientific seal of approval.

The medication, developed by GlaxoSmithKline (GSK), has been awarded “positive scientific opinion” by the European Medicines Agency, passing tests for safety and effectiveness.